FR2730811B1 - Procede pour diagnostiquer et/ou suivre l'evolution d'un desordre capillaire et/ou mesurer l'efficacite d'un traitement applique pour combattre un desordre capillaire - Google Patents

Procede pour diagnostiquer et/ou suivre l'evolution d'un desordre capillaire et/ou mesurer l'efficacite d'un traitement applique pour combattre un desordre capillaire

Info

Publication number
FR2730811B1
FR2730811B1 FR9501881A FR9501881A FR2730811B1 FR 2730811 B1 FR2730811 B1 FR 2730811B1 FR 9501881 A FR9501881 A FR 9501881A FR 9501881 A FR9501881 A FR 9501881A FR 2730811 B1 FR2730811 B1 FR 2730811B1
Authority
FR
France
Prior art keywords
hair disorder
combat
diagnosing
evolution
effectiveness
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9501881A
Other languages
English (en)
Other versions
FR2730811A1 (fr
Inventor
Yann Mahe
Bruno Buan
Genevieve Loussouarn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Priority to FR9501881A priority Critical patent/FR2730811B1/fr
Publication of FR2730811A1 publication Critical patent/FR2730811A1/fr
Application granted granted Critical
Publication of FR2730811B1 publication Critical patent/FR2730811B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G01N33/6869—Interleukin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/88—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving prostaglandins or their receptors

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cosmetics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
FR9501881A 1995-02-17 1995-02-17 Procede pour diagnostiquer et/ou suivre l'evolution d'un desordre capillaire et/ou mesurer l'efficacite d'un traitement applique pour combattre un desordre capillaire Expired - Fee Related FR2730811B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR9501881A FR2730811B1 (fr) 1995-02-17 1995-02-17 Procede pour diagnostiquer et/ou suivre l'evolution d'un desordre capillaire et/ou mesurer l'efficacite d'un traitement applique pour combattre un desordre capillaire

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9501881A FR2730811B1 (fr) 1995-02-17 1995-02-17 Procede pour diagnostiquer et/ou suivre l'evolution d'un desordre capillaire et/ou mesurer l'efficacite d'un traitement applique pour combattre un desordre capillaire

Publications (2)

Publication Number Publication Date
FR2730811A1 FR2730811A1 (fr) 1996-08-23
FR2730811B1 true FR2730811B1 (fr) 1997-03-21

Family

ID=9476282

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9501881A Expired - Fee Related FR2730811B1 (fr) 1995-02-17 1995-02-17 Procede pour diagnostiquer et/ou suivre l'evolution d'un desordre capillaire et/ou mesurer l'efficacite d'un traitement applique pour combattre un desordre capillaire

Country Status (1)

Country Link
FR (1) FR2730811B1 (fr)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE43372E1 (en) 1999-03-05 2012-05-08 Duke University C16 unsaturated FP-selective prostaglandins analogs
US8541466B2 (en) 2000-03-31 2013-09-24 Duke University Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US8618086B2 (en) 2000-03-31 2013-12-31 Duke University Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
US8623918B2 (en) 2008-10-29 2014-01-07 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US8722739B2 (en) 2008-10-29 2014-05-13 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US9346837B2 (en) 2000-03-31 2016-05-24 Duke University Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6894175B1 (en) 1999-08-04 2005-05-17 The Procter & Gamble Company 2-Decarboxy-2-phosphinico prostaglandin derivatives and methods for their preparation and use
EP1487396A1 (fr) 2002-03-28 2004-12-22 The Procter & Gamble Company Compositions de stabilisation de particules
FR2854243A1 (fr) * 2003-04-24 2004-10-29 Oreal Procede de determination d'etats pre-alopeciques et/ou d'atteintes cutanees au moyen d'un marqueur predictif: hif-1(hypoxia inducible factor-1)
FR2916350B1 (fr) * 2007-05-22 2009-07-24 Oreal Utilisation d'agonistes du recepteur du thromboxame pour moduler la croissance pilaire

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8928634D0 (en) * 1989-12-19 1990-02-21 Unilever Plc Method of testing
FR2671562B1 (fr) * 1991-01-16 1995-09-15 Oreal Procede de diagnostic d'un etat d'inflammation ou de vieillissement cellulaire des keratinocytes, et necessaire pour la mise en óoeuvre de ce procede.
FR2679659B1 (fr) * 1991-07-23 1993-11-19 Medgenix Diagnostic Sa Procede de dosage in vitro de molecules au niveau de leur site de production par des cellules en culture et format technologique adapte.

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE43372E1 (en) 1999-03-05 2012-05-08 Duke University C16 unsaturated FP-selective prostaglandins analogs
US8541466B2 (en) 2000-03-31 2013-09-24 Duke University Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US8618086B2 (en) 2000-03-31 2013-12-31 Duke University Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
US8906962B2 (en) 2000-03-31 2014-12-09 Duke University Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US9346837B2 (en) 2000-03-31 2016-05-24 Duke University Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US9579270B2 (en) 2000-03-31 2017-02-28 Duke University Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US8623918B2 (en) 2008-10-29 2014-01-07 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US8722739B2 (en) 2008-10-29 2014-05-13 Novaer Holdings, Inc. Amino acid salts of prostaglandins

Also Published As

Publication number Publication date
FR2730811A1 (fr) 1996-08-23

Similar Documents

Publication Publication Date Title
FR2667944B1 (fr) Trousse et procede de diagnostic pour le diagnostic precoce des douleurs thoraciques.
DE69328881D1 (de) Telemetriesystem für eine Vorrichtung zum Erkennen und Behandeln von Tachyarrhythmien
FR2750050B1 (fr) Dispositif pour le traitement topique de l'acne et son procede de fabrication
DE69529307D1 (de) Ultraschall-Diagnose- und Behandlungssystem
OA08621A (fr) Procédé et installation de traitement à l'anmoniac.
FR2612319B1 (fr) Procede et dispositif de controle de l'utilisation d'un ou de plusieurs vehicules
FR2730811B1 (fr) Procede pour diagnostiquer et/ou suivre l'evolution d'un desordre capillaire et/ou mesurer l'efficacite d'un traitement applique pour combattre un desordre capillaire
FR2647675B1 (fr) Utilisation d'un derive de la statine dans le traitement des affections oculaires
FR2611729B1 (fr) Procede de preparation d'un organopolysiloxane a fonction acrylate et/ou methacrylate
FR2589485B1 (fr) Magnesium ou alliage du magnesium traite en surface et procede pour le traitement de surface du magnesium ou d'un alliage de magnesium
FR2767040B1 (fr) Dispositif pour le traitement et/ou le maquillage des fibres keratiniques
BE864083A (fr) Procede et ensemble de reactifs pour la mise en evidence et l'evaluation de la lipoproteine x
FR2595681B1 (fr) Traitement de l'eau et analyse des sols
FR2751072B1 (fr) Dispositif et procede pour l'execution de mesures interferometriques
PT75378B (fr) Procede et dispositif pour l'amerioration des conditions de formation de matelas de fibres
FR2643135B1 (fr) Vehicule d'exploration et de maintenance des tubes de generateurs de vapeur ou similaires
DE59610248D1 (de) Verfahren zur diagnose und therapie von plattenepithelkarzinomen
FR2741355B1 (fr) Composition pour le traitement d'objets que l'on souhaite nettoyer et/ou desinfecter
FR2509878B1 (fr) Procede et appareil pour controler l'activite d'une solution de developpement et s'opposer a son noircissement en utilisant une eprouvette
FR2765485B1 (fr) Procede et dispositif pour le traitement anti-odeur de l'air
FR2731289B1 (fr) Procede et dispositif d'amelioration de la securite des etres vivants et plus particulierement des personnes
FR2674844B1 (fr) Procede et installation de traitement d'epuration de lisiers d'animaux.
FR2734731B1 (fr) Procede et dispositif de stimulation cardiaque en presence d'interferences electromagnetiques
FR2630099B1 (fr) Procede de traitement et de purification d'eaux
FR2742339B1 (fr) Procede et dispositif electromagnetique de stimulation cutanee pour le traitement d'etats pathologiques

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20111102